Disease mitigation measures in the control of pandemic influenza.

The threat of an influenza pandemic has alarmed countries around the globe and given rise to an intense interest in disease mitigation measures. This article reviews what is known about the effectiveness and practical feasibility of a range of actions that might be taken in attempts to lessen the number of cases and deaths resulting from an influenza pandemic. The article also discusses potential adverse second- and third-order effects of mitigation actions that decision makers must take into account. Finally, the article summarizes the authors' judgments of the likely effectiveness and likely adverse consequences of the range of disease mitigation measures and suggests priorities and practical actions to be taken.

[1]  H. Oshitani,et al.  Potential benefits and limitations of various strategies to mitigate the impact of an influenza pandemic , 2006, Journal of Infection and Chemotherapy.

[2]  D. Wagener,et al.  State Plans for Containment of Pandemic Influenza , 2006, Emerging infectious diseases.

[3]  M. Berkwits,et al.  The Health Care Response to Pandemic Influenza , 2006, Annals of Internal Medicine.

[4]  John Bartlett,et al.  Planning for Avian Influenza , 2006, Annals of Internal Medicine.

[5]  T. O'Toole,et al.  Hospital preparedness for pandemic influenza. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[6]  T. O'Toole,et al.  Comments from the Center for Biosecurity of UPMC on proposed revisions to federal quarantine rules. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[7]  Thomas V Inglesby,et al.  Systemic collapse: Medical care in the aftermath of Hurricane Katrina. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[8]  T. Lancet.  A reappraisal of H5N1 avian influenza , 2006, The Lancet.

[9]  N. Ferguson,et al.  Will travel restrictions control the international spread of pandemic influenza? , 2006, Nature Medicine.

[10]  Sandra Mounier-Jack,et al.  How prepared is Europe for pandemic influenza? Analysis of national plans , 2006, The Lancet.

[11]  E. Toner.  Do public health and infection control measures prevent the spread of flu? , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[12]  Tiina Reponen,et al.  Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? , 2006, American journal of infection control.

[13]  P. Horby,et al.  Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.

[14]  Comments from the Center for Biosecurity of UPMC on the National Strategy for Pandemic Influenza: Implementation Plan. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[15]  T. Inglesby,et al.  Working Group on Pandemic Influenza Preparedness: joint statement in response to Department of Health and Human Services Pandemic Influenza Plan. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  N. Crepaz,et al.  Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States , 2011, Cancer Causes & Control.

[17]  D. Talmor,et al.  Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: Recommendations of the Working Group on Emergency Mass Critical Care‡ , 2005, Critical care medicine.

[18]  Stanley M Lemon,et al.  The threat of pandemic influenza: are we ready? , 2005, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[19]  P. Ward,et al.  Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. , 2005, The Journal of antimicrobial chemotherapy.

[20]  T. Tam,et al.  Border Screening for SARS , 2005, Emerging infectious diseases.

[21]  L. Chiarello,et al.  Healthcare Settings as Amplifiers of Infectious Disease , 2004, Emerging infectious diseases.

[22]  F. Hayden.  Pandemic Influenza: Is an Antiviral Response Realistic? , 2004, The Pediatric infectious disease journal.

[23]  David M. Bell,et al.  Public Health Interventions and SARS Spread, 2003 , 2004, Emerging infectious diseases.

[24]  Dan Hanfling,et al.  Health care facility and community strategies for patient care surge capacity☆☆☆ , 2004, Annals of Emergency Medicine.

[25]  Gabriel Chodick,et al.  INFLUENCE OF SCHOOL CLOSURE ON THE INCIDENCE OF VIRAL RESPIRATORY DISEASES AMONG CHILDREN AND ON HEALTH CARE UTILIZATION , 2004, The Pediatric infectious disease journal.

[26]  Constance Schultsz,et al.  Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.

[27]  V. Lovell,et al.  No Time to be Sick: Why Everyone Suffers When Workers Don't Have Paid Sick Leave , 2004 .

[28]  C. Digiovanni,et al.  Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak. , 2004, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[29]  C. Bridges,et al.  Transmission of influenza: implications for control in health care settings. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  R. Schabas,et al.  SARS: prudence, not panic. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[31]  Efficiency of quarantine during an epidemic of severe acute respiratory syndrome--Beijing, China, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[32]  Lewis Rubinson,et al.  The challenge of hospital infection control during a response to bioterrorist attacks. , 2003, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[33]  L. Gostin,et al.  Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. , 2001, JAMA.

[34]  M. Ryan,et al.  Handwashing and respiratory illness among young adults in military training. , 2001, American journal of preventive medicine.

[35]  J. R. Scotti,et al.  Available From , 1973 .

[36]  J. Stoker,et al.  The Department of Health and Human Services. , 1999, Home healthcare nurse.

[37]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[38]  One Gateway Plaza,et al.  Metropolitan Transportation Authority , 1998 .

[39]  Fenguangzhai Song.  CD , 1992 .

[40]  J K Albrecht,et al.  Influenza B in households: virus shedding without symptoms or antibody response. , 1987, American journal of epidemiology.

[41]  N. Grist.  Pandemic influenza 1918. , 1979, British medical journal.

[42]  D. J. Davis,et al.  Epidemiologic studies on influenza in familial and general population groups, 1951-1956. II. Characteristics of occurrence. , 1961, American journal of hygiene.

[43]  D. J. Davis,et al.  Epidemiologic studies on influenza in familial and general population groups. 1951-1956. III. Laboratory observations. , 1961, American journal of hygiene.

[44]  W. Lennox.  NEWER KNOWLEDGE OF EPILEPSY , 1943 .

[45]  E. O. Jordan,et al.  Influenza in Three Chicago Groups , 1919 .